TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
MDT

Medtronic PLC

Healthcare · Medical Devices

88.60$ +0.1% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Ratios

Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.

Tick rows to compare them in a chart (up to 4)

Ratios MDT
Line item 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Valuation
34.7 52.5 92.7 57.8 52.3 55.6 36.6 31.6 35.6 23.9 21.9 24.9 16.6 15.6 14.6 11.2 13.8 19.4 30.9 31.9 28.7 35.3 26.0 27.5 49.2 28.0 32.3 29.0 23.5 21.7
8.3 12.0 10.5 12.7 9.8 8.5 7.6 6.8 6.4 5.4 5.0 4.1 2.5 3.1 2.8 2.5 2.9 3.5 4.1 3.9 3.9 3.7 3.9 4.6 5.9 4.5 3.9 3.3 3.3 2.9
11.6 15.3 11.5 14.1 9.9 8.5 7.4 6.8 6.1 6.5 5.6 4.8 2.8 3.3 2.8 2.4 2.6 3.1 1.6 2.2 2.3 2.2 2.4 2.6 3.4 2.7 2.4 2.1 2.3 2.1
8.3 11.9 10.5 12.6 9.7 8.9 7.8 6.9 6.4 5.8 5.4 4.5 2.9 3.6 3.4 3.1 3.5 4.1 5.6 4.9 4.8 4.4 4.6 5.3 6.6 5.1 4.6 4.0 4.0 3.6
19.2 24.6 27.5 32.9 24.7 22.9 19.4 17.3 16.5 15.5 15.3 16.3 12.0 11.1 10.9 9.4 10.6 14.2 20.9 16.6 16.7 13.9 15.2 19.5 26.6 18.4 16.6 15.9 14.7 13.3
73.9 70.6 – 90.7 39.3 45.5 34.5 25.6 27.1 63.3 26.9 19.3 11.2 13.9 14.2 10.5 10.8 13.1 19.1 27.1 20.6 30.3 20.5 21.9 36.3 23.6 26.5 20.5 21.1 19.2
1.4% 1.4% -1.8% 1.1% 2.5% 2.2% 2.9% 3.9% 3.7% 1.6% 3.7% 5.2% 8.9% 7.2% 7.1% 9.5% 9.2% 7.7% 5.2% 3.7% 4.9% 3.3% 4.9% 4.6% 2.8% 4.2% 3.8% 4.9% 4.7% 5.2%
Margins
95.0% 103.0% 80.9% 79.7% 79.9% 74.2% 75.3% 75.2% 75.7% 75.1% 74.2% 74.5% 75.9% 74.7% 74.1% 76.0% 75.1% 74.5% 68.9% 68.3% 68.7% 69.7% 70.0% 67.4% 65.2% 68.0% 65.7% 65.3% 65.3% 65.0%
37.5% 41.9% 32.9% 33.6% 33.8% 33.5% 34.6% 35.0% 34.3% 32.8% 30.4% 27.0% 23.7% 30.3% 28.0% 27.7% 26.5% 22.4% 18.6% 18.6% 18.1% 22.2% 20.5% 16.6% 14.9% 18.2% 17.6% 15.9% 17.8% 17.8%
23.9% 22.8% 11.3% 21.9% 18.8% 15.3% 20.9% 21.6% 17.9% 22.6% 22.8% 16.5% 14.9% 19.6% 19.4% 22.3% 20.9% 18.0% 13.2% 12.3% 13.6% 10.4% 15.2% 16.6% 12.0% 15.9% 12.0% 11.4% 13.9% 13.2%
11.2% 17.0% -19.1% 14.0% 25.1% 18.8% 22.1% 26.6% 23.5% 8.5% 18.6% 21.3% 22.0% 22.1% 20.0% 23.8% 26.7% 26.8% 21.4% 14.5% 18.9% 12.1% 19.2% 20.8% 16.2% 18.9% 14.7% 16.1% 15.5% 14.9%
Returns
33.4% 29.1% 12.4% 24.5% 19.0% 15.3% 20.2% 21.6% 17.3% 27.1% 25.5% 19.3% 16.9% 21.2% 19.4% 21.1% 18.6% 15.8% 5.0% 6.8% 8.0% 6.1% 9.2% 9.4% 7.0% 9.6% 7.3% 7.3% 9.7% 9.7%
24.2% 21.4% 9.6% 19.4% 14.9% 9.0% 13.0% 13.9% 10.9% 13.0% 14.4% 10.1% 9.2% 11.0% 10.2% 10.9% 10.0% 8.1% 2.5% 3.6% 4.0% 3.4% 5.2% 5.3% 3.9% 5.5% 4.1% 4.1% 5.1% 5.2%
Balance Sheet & Debt
-91 -252 17 -117 -872 2,115 896 766 220 4,929 4,831 5,861 5,969 8,119 8,453 9,399 9,681 10,525 31,301 28,444 28,456 22,072 20,921 20,612 22,796 20,400 22,821 23,685 26,246 25,958
-0.1 -0.2 0.0 -0.1 -0.4 0.9 0.3 0.2 0.1 1.2 1.1 1.6 1.7 1.6 1.7 1.8 1.8 2.1 5.7 3.3 3.3 2.3 2.2 2.6 3.0 2.3 2.6 2.9 2.8 2.6
72.5% 73.7% 77.4% 79.2% 78.3% 59.0% 64.2% 64.3% 62.9% 47.7% 56.3% 52.0% 54.3% 52.1% 52.5% 51.7% 53.7% 51.2% 49.9% 52.1% 50.4% 55.5% 55.8% 55.9% 55.2% 57.8% 56.6% 55.8% 52.4% 53.2%
0.1 0.1 0.1 0.1 0.0 0.4 0.3 0.3 0.2 0.8 0.6 0.6 0.6 0.7 0.6 0.6 0.6 0.6 0.7 0.6 0.7 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.6 0.6
Per Share
0.50 0.51 0.39 0.90 0.85 0.80 1.30 1.60 1.48 2.09 2.41 1.95 1.93 2.79 2.86 3.41 3.37 3.02 2.41 2.48 2.89 2.27 3.41 3.54 2.66 3.73 2.82 2.76 3.61 3.73
2.09 2.21 3.42 4.10 4.53 5.24 6.24 7.42 8.25 9.28 10.59 11.83 12.96 14.26 14.73 15.27 16.15 16.78 18.27 20.22 21.35 21.89 22.51 21.40 22.24 23.45 23.43 24.33 26.00 28.23
1.50 1.74 3.12 3.67 4.49 5.25 6.44 7.41 8.57 7.71 9.45 10.10 11.41 13.19 14.76 16.15 18.17 19.18 48.00 36.35 36.15 37.07 36.90 37.55 37.98 38.89 38.63 37.75 37.23 38.40
0.23 0.38 -0.65 0.57 1.14 0.98 1.38 1.98 1.94 0.79 1.97 2.52 2.85 3.15 2.95 3.64 4.31 4.50 3.91 2.93 4.04 2.64 4.33 4.46 3.61 4.42 3.44 3.91 4.02 4.21

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?